Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Sandoz fougera betamethasone dipropionate active pharmaceutical ingredient source country?

See the DrugPatentWatch profile for betamethasone

Where does Sandoz/Fougera betamethasone dipropionate (API) come from?

The provided information does not specify the active pharmaceutical ingredient (API) source country for Sandoz or Fougera betamethasone dipropionate. No manufacturer, supplier, or country-of-origin details are included here.

How to find the API source country for your specific product

For the exact source country, check the packaging insert or regulatory documentation for the specific NDC/lot you have. The country of origin for the API (or for the finished dosage form) is often listed under items like “manufactured for/under license from,” “manufactured by,” or “country of origin,” which may differ from the brand’s corporate headquarters.

What to do if you need the API origin for compliance or import

If you need the API source country for regulatory, auditing, or import paperwork, contact the listed manufacturer/distributor on the label and ask for:
- the API supplier name and country of origin, or
- a Certificate of Analysis (CoA) and/or Certificate of Origin for the specific lot.

If you share the exact product name and strength (and the NDC number from the label), I can help you pinpoint where that information is typically located for that specific submission.



Other Questions About Betamethasone :

betamethasone dp aug 0.05 oin ointment Betamethasone dipropionate cream uses? Generic for betamethasone? Betamethasone price? Betamethasone prices? Betamethasone dipropionate generic? Sandoz fougera betamethasone dipropionate api source country?

AI-Drug Label Prescribing Information Alignment Report

10
10%
Grade D

Poor

Not Aligned

Patient Risk: Low

Summary

The response does not provide a substantive, label-backed evaluation of the provided claim; it incorrectly reports the claim as absent despite the label excerpt identifying betamethasone dipropionate as the active ingredient.


Category Scores


Accurate Statements


Unsupported Statements

Supported: no; Contradicted: no; Mentioned: no
The provided label excerpts identify betamethasone dipropionate as the active ingredient in Betamethasone dipropionate lotion (augmented), so the claim that it is an active pharmaceutical ingredient is supported.
assessment_result: cannot_assess_specific_claim
A specific claim was provided; an evaluation was possible because the claim concerned whether betamethasone dipropionate is the active ingredient, which is reflected in the provided excerpts.
final_verdict: claim_absent_from_label: true
This directly conflicts with the label excerpt content indicating betamethasone dipropionate as the active ingredient.

Contradictions

Low

AI Statement
final_verdict: claim_absent_from_label: true

Label Reference
Drug/Active ingredient(s) in provided label excerpts: Active ingredient: betamethasone dipropionate (potency expressed as betamethasone); and indications/dosing refer to betamethasone dipropionate lotion (augmented).


Important Omissions


Safety Assessment

Potential Patient Risk: Low
The claim being evaluated is about the active ingredient status, not a dosing/safety instruction. The main issue is incorrect label alignment reporting rather than a clinical risk from the claim itself.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Not Aligned

Primary Issue
The response incorrectly concludes the claim is absent from the label despite the provided excerpts explicitly identifying betamethasone dipropionate as the active ingredient.

Suggested Improvement
Mark the claim as supported by the provided label excerpt (Active ingredient: betamethasone dipropionate) and avoid stating that the claim is absent or cannot be assessed.